Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.

Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.

Clin Exp Immunol. 2000 Aug;121(2):346-52. Unique Identifier : AIDSLINE MED/20389941
Uronen H; Callard RE; Immunobiology Unit, Institute of Child Health, University College; London, London, UK.

Abstract: The aim of this study was to investigate the effect of absent CD40-CD40 ligand interactions in patients with X-linked hyper-IgM syndrome (XHIGM) on the generation of Th1 and Th2 immunity. Whole blood from patients and sex- and age-matched controls was stimulated with phorbol myristate acetate (PMA) and calcium ionophore A23187 in the presence of Brefeldin A. After 5 h, cellular production of interferon-gamma, IL-4, tumour necrosis factor-alpha and IL-2 was measured by intracellular cytokine staining and flow cytometry. This method has been shown previously to preferentially activate memory T cells and in preliminary experiments cells making these cytokines were found to be predominantly CD45RO+. No differences in the proportion of T cells (CD3+) or T cell subsets (CD4+/CD8+) secreting these cytokines between XHIGM patients and age- and sex-matched controls were observed. In addition, production of IL-12 and IL-6 by monocytes in response to lipopolysaccharide and CD40 stimulation was equivalent in patients and controls. These results suggest that development of Th1 or Th2 memory cells in patients with XHIGM is unaffected by the absence of functional CD40 ligand. Rather, the susceptibility of these patients to intracellular pathogens, such as Pneumocystis carinii and Cryptosporidium parvum, is more likely to be due to an inability to activate the effector arm of the cellular immune response.

Keywords: JOURNAL ARTICLE Adolescence Adult Antigens, CD14/ANALYSIS Antigens, CD3/ANALYSIS Antigens, CD40/*PHYSIOLOGY Calcimycin/PHARMACOLOGY Calcium/PHYSIOLOGY Cell Differentiation Child Child, Preschool Comparative Study CD8-Positive T-Lymphocytes/DRUG EFFECTS/IMMUNOLOGY/SECRETION Female Human Hypergammaglobulinemia/GENETICS/*IMMUNOLOGY IgM/*IMMUNOLOGY Immunologic Memory Infant Ionophores/PHARMACOLOGY Lipopolysaccharides/PHARMACOLOGY Lymphocyte Transformation/DRUG EFFECTS Lymphokines/SECRETION Male Membrane Glycoproteins/*DEFICIENCY/GENETICS/PHYSIOLOGY Monocytes/DRUG EFFECTS/SECRETION Monokines/SECRETION Support, Non-U.S. Gov't Syndrome Tetradecanoylphorbol Acetate/PHARMACOLOGY Th1 Cells/DRUG EFFECTS/*IMMUNOLOGY/SECRETION Th2 Cells/DRUG EFFECTS/*IMMUNOLOGY/SECRETION X Chromosome/*GENETICS

001130
A00B1157

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .